AJTMH HINARI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am. J. Trop. Med. Hyg., 67(1), 2002, pp. 28-31
Copyright © 2002 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kofoed, P.
Right arrow Articles by Rombo, L
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kofoed, P.
Right arrow Articles by Rombo, L
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CHLOROQUINE
Related Collections
Right arrow Malaria
American Journal of Tropical Medicine and Hygiene, Vol 67, Issue 1, 28-31
Copyright © 2002 by American Society of Tropical Medicine and Hygiene

Research Articles


Treatment of children with Plasmodium falciparum malaria with chloroquine in Guinea-Bissau

PE Kofoed, F Lopez, P Johansson, A Sandstrom, K Hedegaard, P Aaby, and L Rombo

Children with symptomatic malaria in Bissau, Guinea-Bissau were randomly assigned to treatment with a 25 mg/kg total dose of chloroquine as recommended by the National Malaria Program or with a higher total dose of 50 mg/kg. Sixty-seven and 62 children, respectively, completed the treatment and were then followed once a week for five weeks. Treatment with a dose of 50 mg/kg was significantly more effective than treatment with 25 mg/kg in preventing recrudescence. The cumulative relative risk (95% confidence interval) of having parasitemia in the low-dose group during follow-up was 0.20 (0.08-0.52) on day 21, 0.38 (0.17-0.86) on day 28, and 0.48 (0.23-0.98) on day 35. Few adverse events were reported, although more children complained of vomiting and diarrhea on day 2 in the high-dose group compared with those in the low-dose group. However, this difference was not statistically significant. We conclude that a dose of 50 mg/kg of chloroquine could be recommended for treatment of Plasmodium falciparum malaria in Bissau. To minimize the risk of side effects, this higher dose should be given divided into two daily doses over a three-day period.


This article has been cited by other articles:


Home page
 Am J Trop Med HygHome page
J. URSING, P.-E. KOFOED, A. RODRIGUES, L. ROMBO, and J. P. GIL
PLASMODIUM FALCIPARUM GENOTYPES ASSOCIATED WITH CHLOROQUINE AND AMODIAQUINE RESISTANCE IN GUINEA-BISSAU
Am J Trop Med Hyg, May 1, 2007; 76(5): 844 - 848.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
R. Kobbe, C. G. Meyer, J. May, J. Ursing, A. Rodrigues, P.-E. Kofoed, A. S. Muula, M. K. Laufer, C. V. Plowe, and T. E. Taylor
Chloroquine-Resistant Malaria in Malawi
N. Engl. J. Med., February 22, 2007; 356(8): 868 - 869.
[Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
K. Stepniewska, W. R.J. Taylor, M. Mayxay, R. Price, F. Smithuis, J.-P. Guthmann, K. Barnes, H. Y. Myint, M. Adjuik, P. Olliaro, et al.
In Vivo Assessment of Drug Efficacy against Plasmodium falciparum Malaria: Duration of Follow-Up
Antimicrob. Agents Chemother., November 1, 2004; 48(11): 4271 - 4280.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Society of Tropical Medicine and Hygiene.